questionsmedicales.fr
Composés hétérocycliques
Composés hétérocycliques à cycles fusionnés
Composés hétérobicycliques
Indolizine
Indolizidines
Alcaloïdes indoliques
Alcaloïdes formés par condensation de sécologanine et de tryptamine
Alcaloïdes de Vinca
Vincristine
Vincristine : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
2
Vincristine
Cancer
Diagnostic
Tests de laboratoire
Imagerie médicale
Vincristine
Symptômes
2
Effets secondaires
Neuropathie
Vincristine
Douleur
Neuropathie
Vincristine
Prévention
2
Prévention
Effets secondaires
Vincristine
Évaluation médicale
Vincristine
Préparation au traitement
Traitements
2
Chimiothérapie
Vincristine
Prednisone
Administration intraveineuse
Vincristine
Chimiothérapie
Complications
2
Complications
Infections
Vincristine
Problèmes cardiaques
Vincristine
Surveillance médicale
Facteurs de risque
2
Facteurs de risque
Neuropathie
Vincristine
Antécédents médicaux
Vincristine
Neurologie
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vincristine : Questions médicales les plus fréquentes",
"headline": "Vincristine : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vincristine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-27",
"dateModified": "2025-02-21",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vincristine"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Alcaloïdes de Vinca",
"url": "https://questionsmedicales.fr/mesh/D014748",
"about": {
"@type": "MedicalCondition",
"name": "Alcaloïdes de Vinca",
"code": {
"@type": "MedicalCode",
"code": "D014748",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.496.500.500.681.827"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Vincristine",
"alternateName": "Vincristine",
"code": {
"@type": "MedicalCode",
"code": "D014750",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Wenjian Yang",
"url": "https://questionsmedicales.fr/author/Wenjian%20Yang",
"affiliation": {
"@type": "Organization",
"name": "Hematological Malignancies Program and Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA."
}
},
{
"@type": "Person",
"name": "Deqing Pei",
"url": "https://questionsmedicales.fr/author/Deqing%20Pei",
"affiliation": {
"@type": "Organization",
"name": "Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA."
}
},
{
"@type": "Person",
"name": "Cheng Cheng",
"url": "https://questionsmedicales.fr/author/Cheng%20Cheng",
"affiliation": {
"@type": "Organization",
"name": "Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA."
}
},
{
"@type": "Person",
"name": "William E Evans",
"url": "https://questionsmedicales.fr/author/William%20E%20Evans",
"affiliation": {
"@type": "Organization",
"name": "Hematological Malignancies Program and Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA."
}
},
{
"@type": "Person",
"name": "Richard H Ho",
"url": "https://questionsmedicales.fr/author/Richard%20H%20Ho",
"affiliation": {
"@type": "Organization",
"name": "Vanderbilt University Medical Center, Nashville, TN."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Dry powder inhalation, part 1: ancient history and precursors to modern dry powder inhalers.",
"datePublished": "2022-08-18",
"url": "https://questionsmedicales.fr/article/35982634",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/17425247.2022.2112568"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dry powder inhalers of antitubercular drugs.",
"datePublished": "2022-06-24",
"url": "https://questionsmedicales.fr/article/35779497",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.tube.2022.102228"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of spray-dried N-acetylcysteine dry powder for inhalation.",
"datePublished": "2022-12-25",
"url": "https://questionsmedicales.fr/article/36577481",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijpharm.2022.122550"
}
},
{
"@type": "ScholarlyArticle",
"name": "Spray dried progesterone formulations for carrier free dry powder inhalation.",
"datePublished": "2023-06-29",
"url": "https://questionsmedicales.fr/article/37392870",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejpb.2023.06.018"
}
},
{
"@type": "ScholarlyArticle",
"name": "Smart Specification Setting for Dry Powder Inhalation Carriers.",
"datePublished": "2023-02-28",
"url": "https://questionsmedicales.fr/article/36858177",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.xphs.2023.02.018"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérobicycliques",
"item": "https://questionsmedicales.fr/mesh/D006574"
},
{
"@type": "ListItem",
"position": 5,
"name": "Indolizine",
"item": "https://questionsmedicales.fr/mesh/D007212"
},
{
"@type": "ListItem",
"position": 6,
"name": "Indolizidines",
"item": "https://questionsmedicales.fr/mesh/D054836"
},
{
"@type": "ListItem",
"position": 7,
"name": "Alcaloïdes indoliques",
"item": "https://questionsmedicales.fr/mesh/D026121"
},
{
"@type": "ListItem",
"position": 8,
"name": "Alcaloïdes formés par condensation de sécologanine et de tryptamine",
"item": "https://questionsmedicales.fr/mesh/D046948"
},
{
"@type": "ListItem",
"position": 9,
"name": "Alcaloïdes de Vinca",
"item": "https://questionsmedicales.fr/mesh/D014748"
},
{
"@type": "ListItem",
"position": 10,
"name": "Vincristine",
"item": "https://questionsmedicales.fr/mesh/D014750"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vincristine - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vincristine",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vincristine",
"description": "Comment la vincristine est-elle utilisée dans le diagnostic ?\nQuels tests précèdent l'administration de vincristine ?",
"url": "https://questionsmedicales.fr/mesh/D014750?mesh_terms=Dry+Powder+Inhalers#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vincristine",
"description": "Quels sont les effets secondaires de la vincristine ?\nLa vincristine cause-t-elle des douleurs ?",
"url": "https://questionsmedicales.fr/mesh/D014750?mesh_terms=Dry+Powder+Inhalers#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vincristine",
"description": "Peut-on prévenir les effets secondaires de la vincristine ?\nY a-t-il des recommandations avant le traitement par vincristine ?",
"url": "https://questionsmedicales.fr/mesh/D014750?mesh_terms=Dry+Powder+Inhalers#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vincristine",
"description": "Avec quels médicaments la vincristine est-elle souvent combinée ?\nComment la vincristine est-elle administrée ?",
"url": "https://questionsmedicales.fr/mesh/D014750?mesh_terms=Dry+Powder+Inhalers#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vincristine",
"description": "Quelles complications peuvent survenir avec la vincristine ?\nLa vincristine peut-elle causer des problèmes cardiaques ?",
"url": "https://questionsmedicales.fr/mesh/D014750?mesh_terms=Dry+Powder+Inhalers#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vincristine",
"description": "Qui est à risque d'effets indésirables de la vincristine ?\nLes antécédents médicaux influencent-ils le traitement par vincristine ?",
"url": "https://questionsmedicales.fr/mesh/D014750?mesh_terms=Dry+Powder+Inhalers#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment la vincristine est-elle utilisée dans le diagnostic ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vincristine n'est pas un outil de diagnostic, mais un traitement pour des cancers diagnostiqués."
}
},
{
"@type": "Question",
"name": "Quels tests précèdent l'administration de vincristine ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des examens d'imagerie sont effectués pour évaluer la maladie."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires de la vincristine ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent neuropathie, constipation, et fatigue."
}
},
{
"@type": "Question",
"name": "La vincristine cause-t-elle des douleurs ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut provoquer des douleurs neuropathiques chez certains patients."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les effets secondaires de la vincristine ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mesures préventives incluent une surveillance étroite et des médicaments pour les symptômes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations avant le traitement par vincristine ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une évaluation médicale complète est recommandée avant le traitement."
}
},
{
"@type": "Question",
"name": "Avec quels médicaments la vincristine est-elle souvent combinée ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle est souvent combinée avec la prednisone et d'autres agents chimiothérapeutiques."
}
},
{
"@type": "Question",
"name": "Comment la vincristine est-elle administrée ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vincristine est administrée par voie intraveineuse, généralement en cycle."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la vincristine ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des infections, des troubles neurologiques et des problèmes gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "La vincristine peut-elle causer des problèmes cardiaques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Bien que rare, des problèmes cardiaques peuvent survenir, nécessitant une surveillance."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'effets indésirables de la vincristine ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients âgés et ceux avec des antécédents de neuropathie sont à risque accru."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils le traitement par vincristine ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies neurologiques peuvent affecter le traitement."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 21/02/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Hematological Malignancies Program and Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publications dans "Vincristine" :
3 publications dans cette catégorie
Affiliations :
Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publications dans "Vincristine" :
3 publications dans cette catégorie
Affiliations :
Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publications dans "Vincristine" :
3 publications dans cette catégorie
Affiliations :
Hematological Malignancies Program and Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publications dans "Vincristine" :
3 publications dans cette catégorie
Affiliations :
Vanderbilt University Medical Center, Nashville, TN.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, 1081 HV Amsterdam, The Netherlands.
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, 1081 HV Amsterdam, The Netherlands.
Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, 1081 HV Amsterdam, The Netherlands.
Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Alcorcón, Spain.
Unidad Asociada al Instituto de Química Medica (IQM) del Consejo Superior de Investigaciones Científicas (CSIC), Universidad Rey Juan Carlos, Alcorcón, Spain.
High Performance Research Group in Experimental Pharmacology (Pharmakom-URJC), URJC, Alcorcón, Spain.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Departamento de Ciencias Básicas de la Salud, Facultad de Ciencias de la Salud, Universidad Rey Juan Carlos, Alcorcón, Spain.
Unidad Asociada al Instituto de Química Medica (IQM) del Consejo Superior de Investigaciones Científicas (CSIC), Universidad Rey Juan Carlos, Alcorcón, Spain.
High Performance Research Group in Experimental Pharmacology (Pharmakom-URJC), URJC, Alcorcón, Spain.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, PR China.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410011, China; Mental Health Institute of the Second Xiangya Hospital, Central South University, Chinese National Clinical Research Center on Mental Disorders (xiangya), Chinese National Technology Institute on Mental Disorders, Hunan Key Laboratory of Psychiatry and Mental Health, Changsha, Hunan 410011, China.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
The Materials Science and Engineering Program, College of Engineering and Applied Science, University of Cincinnati, Cincinnati, OH, United States.
Center for Lung Regenerative Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
Division of Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Division of Pulmonary and Critical Care and Sleep Medicine, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, United States.
Publications dans "Vincristine" :
2 publications dans cette catégorie
Affiliations :
The Materials Science and Engineering Program, College of Engineering and Applied Science, University of Cincinnati, Cincinnati, OH, United States.
Publications dans "Vincristine" :
Inhalation of herbs and other compounds has a long history but habits for medical treatment are intertwined with rituals to obtain hallucinatory effects and pleasurable sensations. Several examples of...
Examples of ancient inhalation and the development of early dry powder inhalers up to and including the first half of the twentieth century. Databases used for literature about historic events, ancien...
Inhalation does not necessarily require active creation of inhalable aerosols, smokes or fumes. Inhaling 'healthy air' with volatile and gaseous components, or fine aerosols in pine forests, on volcan...
Despite advancements in the medical and pharmaceutical fields, tuberculosis remains a major health problem globally. Patients do not widely accept the conventional approach to treating tuberculosis (T...
N-acetylcysteine (NAC) has both antioxidant and immunomodulatory activities and has been used as adjuvant therapy in several viral infections. Recently, NAC attracted attention for its possible role i...
Low oral absorption and extensive first pass metabolism of progesterone is reported for many oral formulations which warrants investigation into other routes of administration. It is the aim of this s...
The specifications of excipients are important to pharmaceutical manufacturers to ensure that the final product can be manufactured robustly over the entire lifecycle of a drug product. Particle size ...
The probability of agglomerate-to-wall collision was quantified using a unique image processing technique applied to high-speed microscopic images. The study aimed to investigate the effects of flow r...
The device consists of a swirl chamber and two tangential inlets in various configurations, designed to emulate the geometric features of commercial devices such as the Aerolizer® and Osmohaler®. The ...
At the lower flow rate of 30 SLPM, collision frequencies were significantly different between powders of different constituent particle sizes, but the effects of powder properties diminished on increa...
Analysis of collision events showed that the probability of collision for each agglomerate increased with agglomerate diameter and velocity. Experimental data of agglomerate-to-wall collision were uti...
The manufacture of modern dry powder inhalers (DPIs), starting with the Spinhaler (Fisons) in 1967, was only possible thanks to a series of technological developments in the 20...
The diversity of currently used DPIs with single dose, multiple-unit dose and multi-dose DPIs is discussed, including the benefits and drawbacks of this diversity for correct use and the efficacy of t...
Considering the relatively poor efficacy regarding lung deposition of currently used DPIs, the high rates of incorrect inhaler use and inhalation errors and the poor adherence to the therapy with inha...
Adherence to inhaled treatments is a complex challenge for patients with chronic obstructive pulmonary disease (COPD) and asthma, it not only involves following the prescribed treatment plans but also...
This article reviews recent developments in computational modeling of dry powder inhalers (DPIs). DPIs deliver drug formulations (sometimes blended with larger carrier particles) to a patient's lungs ...
In dry powder formulations for inhalation, coarse carrier particles are often used to improve handling, dosing and dispersion of the active pharmaceutical ingredient (API). Carrier particles, mostly a...